Product Wiki · Recalls · U.S. CPSC

Recall 21204 — Luyuan Youth All-Terrain Vehicles (ATVs)

U.S. CPSC · United States · 2021-09-29

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. CPSC
Recall identifier
21204
Date of alert
2021-09-29
Country / jurisdiction
United States
Risk type
recall
Product category
consumer_product
Reported risk: The recall involves Luyuan's youth ATVs sold from August 2018 through August 2020 and intended for use by children ages 6 years and older, as demonstrated by the product dimensions and advertising. The ATVs were also marketed on Amazon.com to children as young as 12 months of age and on Walmart.com to children age 5 years. The model numbers include LY-ATV-40A, LY-ATV-40D, LY-ATV-40E and LY-ATV-40I. The model number is printed on the hang tag and the brand name is printed on a sticker on the plastic body. The ATVs may have a label on the front frame, stating: "This ATV is subject to LUYUAN INC's ACTION PLAN approved by U.S. Consumer Product Safety Commission on August 7, 2009" or a label on the motor stating: "IMPORTED BY LUYUAN, INC." Some of these ATVs were sold with GBMOTO or GoBowen branding. The ATVs were sold in various colors. Hazards: The youth ATVs fail to comply with the requirements of the federal mandatory ATV safety standard, including maximum speed limitations and other mandatory safety requirements for vehicles intended for children under 10 years of age. ATVs that fail to meet the mandatory safety requirements pose a risk of serious injury or death to children.
Primary source: https://www.cpsc.gov/Recalls/2021/Luyuan-Recalls-Youth-All-Terrain-Vehicles-ATVs

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.